Cargando…

Algorithm of Femoropopliteal Endovascular Treatment

Background and Objectives: Indications for the endovascular treatment of femoropopliteal lesions have steadily increased over the past decade. Accordingly, the number of devices has also increased, but the choice of the best endovascular treatment remains to be defined. Many devices are now availabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dubosq, Maxime, Raux, Maxime, Nasr, Bahaa, Gouëffic, Yann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501396/ https://www.ncbi.nlm.nih.gov/pubmed/36143968 http://dx.doi.org/10.3390/medicina58091293

Ejemplares similares

When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?
por: AbuRahma, Ali F.
Publicado: (2018)

Outcomes of endovascular treatment of patients with intermittent claudication due to femoropopliteal disease
por: Naiem, Ahmed A, et al.
Publicado: (2021)

Endovascular Sharp Recanalization for Calcified Femoropopliteal Artery Occlusion
por: Huang, Hsuan-Li, et al.
Publicado: (2012)

Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry
por: Vu, Michael H., et al.
Publicado: (2022)

State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?
por: Mosarla, Ramya C., et al.
Publicado: (2022)

Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK
por: Katsanos, Konstantinos, et al.
Publicado: (2016)

Impact of calcification and infrapopliteal outflow on the outcome of endovascular treatment of femoropopliteal occlusive disease
por: de Athayde Soares, Rafael, et al.
Publicado: (2019)

Popliteal access for endovascular procedures in femoropopliteal artery occlusive disease
por: Yilmaz, Seyhan, et al.
Publicado: (2023)

Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass
por: Rumba, Roberts, et al.
Publicado: (2023)

Outcomes of Popliteal-To-Distal Bypass Combined with Femoropopliteal Artery Endovascular Treatment for Critical Limb Ischemia
por: Tsuji, Yoshihiko, et al.
Publicado: (2017)

Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Morphologic Changes of the Femoropopliteal Arterial Segment with Knee Flexion after Endovascular Therapy
por: Sato, Katsutoshi, et al.
Publicado: (2019)

Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence
por: Bishu, Kalkidan, et al.
Publicado: (2015)

Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis
por: Koeckerling, David, et al.
Publicado: (2023)

Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions
por: Kluckner, Michaela, et al.
Publicado: (2022)

Stellarex drug‐coated balloon for treatment of femoropopliteal arterial disease—The ILLUMENATE Global Study: 12‐Month results from a prospective, multicenter, single‐arm study
por: Schroë, Herman, et al.
Publicado: (2017)

Long-Term Outcome of Bypass Surgery versus Endovascular Revascularization in Long Femoropopliteal Lesions
por: Kluckner, Michaela, et al.
Publicado: (2023)

Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial
por: Gouëffic, Yann, et al.
Publicado: (2014)

Intravascular Ultrasound–Guided Femoropopliteal Endovascular Intervention: Could it Become a Standard Procedure?
por: Murata, Naotaka
Publicado: (2023)

Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study
por: Guo, Xiangjiang, et al.
Publicado: (2015)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Endovascular revascularization of TASC C and D femoropopliteal occlusive disease using carbon dioxide as contrast
por: Mendes, Cynthia de Almeida, et al.
Publicado: (2016)

The Effect of Severe Femoropopliteal Arterial Calcification on the Treatment Outcome of Femoropopliteal Intervention in Patients with Ischemic Tissue Loss
por: Lee, Hyun Yong, et al.
Publicado: (2020)

Endovascular Treatment for Critical Limb Ischemia in Type II Diabetes Mellitus Involving Femoropopliteal and Infrapopliteal Segments: Revascularization Strategy
por: Al-Zoubi, Nabil A, et al.
Publicado: (2021)

Single-Center Contemporary Clinical Outcomes after Endovascular Treatment in Patients with De Novo Femoropopliteal Lesions between 2017 and 2019
por: Horie, Kazunori, et al.
Publicado: (2023)

Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study
por: Gahide, Gérald, et al.
Publicado: (2021)

Effective Endovascular Treatment of Calcified Femoropopliteal Disease With Directional Atherectomy and Distal Embolic Protection: Final Results of the DEFINITIVE Ca(++) Trial
por: Roberts, David, et al.
Publicado: (2014)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Retrospective multicenter registry for endovascular treatment with newer devices in over 25‐cm femoropopliteal artery disease: A retrospective observational study
por: Horie, Kazunori, et al.
Publicado: (2022)

Intravascular ultrasound-based decision tree model for the optimal endovascular treatment strategy selection of femoropopliteal artery disease—results from the ONION Study-
por: Yazu, Yuko, et al.
Publicado: (2022)

Importance to Know the Long-Term Outcome after Endovascular Therapy with Bare Metal Stent Implantation for Femoropopliteal Artery Disease
por: Ito, Naruhiko
Publicado: (2022)

A case of occluded femoropopliteal saphenous vein bypass with threatening limb ischemia treated with endovascular stent graft relining
por: Toyoshima, Taku, et al.
Publicado: (2020)

Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound
por: Horie, Kazunori, et al.
Publicado: (2023)

Percutaneous mechanical thrombectomy for treatment of acute femoropopliteal bypass occlusion
por: Lichtenberg, Michael, et al.
Publicado: (2012)

Benefits of Prehabilitation before Complex Aortic Surgery
por: Mesnard, Thomas, et al.
Publicado: (2023)

Endovascular recanalization of chronic total occlusions of the native superficial femoral artery after failed femoropopliteal bypass in patients with critical limb ischemia
por: Minici, Roberto, et al.
Publicado: (2021)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Protocol of the evolution study: A prospective, multicenter, observational study evaluating the effect and health economics of endovascular treatment in patients with moderate and severe calcification of femoropopliteal artery
por: Pan, Jun, et al.
Publicado: (2022)

Femoropopliteal Bypasses with Varicose Great Saphenous Vein
por: Kuma, Sosei, et al.
Publicado: (2022)

Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results
por: Chen, Yue-Xin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8a0ch6v819it98o3fjoigtboij